Pharmaceutical Manufacturing Expert Dave DiProspero Joins CRB!
May 15, 2013
It is well known among residents that the Tri-State area of the Delaware Valley is a hot bed of activity for pharmaceutical research, development, and manufacturing. What many consumers in our region don’t know is that there is an advanced engineering discipline that specializes in the design of facilities and processes to make such drugs available to the public. CRB, a consulting, engineering and construction provider focused on pharmaceutical facilities, is a top ranked US firm located in Plymouth Meeting– and it has just bolstered its capabilities with the new hire of pharmaceutical engineering expert Dave DiProspero.
With over 25 years of experience, DiProspero comes to CRB not just with technical knowledge, but with an impressive presence in the pharmaceutical industry. An active member of the International Society for Pharmaceutical Engineering (ISPE), he currently serves as a Board Advisor for the Oral Solid Dosage (OSD) Community of Practice. In this role, he leads the effort to advise companies on how to safely design processes and facilities to manufacture tablets, capsules, and similar products, all of which ultimately contributes to the safety of the consumer.
“The general trend in the industry is a move toward flexible and efficient cGMP facilities that can manufacture multiple products concurrently. Additionally, as more branded products come off patent, the generic form comes into play and generic pharma manufactures pick up the ball,” said DiProspero. “Still, the quality of the generics must adhere to the same international regulations of the branded product. That’s where process engineers come in – making sure the manufacturing process is safe both for the operators and for the consumers who depend on these medications and in compliance to these regulations.”
In addition to ensuring that facilities are engineered to meet regulatory compliance of the FDA, DiProspero and CRB also design to meet the standards of international regulatory agencies, including the European Medicines Agency (EMA) and the China Food and Drug Administration. Since 1984, CRB has been providing consulting and design services to clients such as Johnson & Johnson, GlaxoSmithKline and Pfizer. The addition of DiProspero further bolsters the firm’s expertise.
“We are really excited to add Dave’s capabilities to our team,” said Paul Skinner, Northeast Regional Leader at CRB. “In addition to his experience as a consulting engineer, he has worked for several equipment vendors designing custom equipment used in OSD manufacturing, which is a great skillset to help our clients meet their challenges. Dave is an industry leader who furthers our position as not only a top design firm but a thought leader helping move the entire industry forward to better provide safe and cost-effective medicines to the public. This is a mission that motivates all of us at CRB.”